{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075375","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.206993+00:00","generated_at":"2026-06-01T00:55:44.215824+00:00","sec_items":["5.02","5.07","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"United Therapeutics shareholders elect Jan Malcolm to board, approve stock plan amendment adding 1.32M shares","bullets":["Jan Malcolm, former Minnesota Health Commissioner, elected to board; replaces Prof. Katherine Klein who did not stand for re-election.","Shareholders approved amendment to 2015 Stock Incentive Plan: adds 1,320,000 shares, extends expiration to April 25, 2034.","All 11 director nominees elected; advisory resolution on executive compensation passed with 94.8% of votes cast.","Ratification of Ernst & Young as independent auditor for 2024 approved by shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075375","json":"https://secwatch.observer/filing/0001104659-24-075375.json","markdown":"https://secwatch.observer/filing/0001104659-24-075375.md","text":"https://secwatch.observer/filing/0001104659-24-075375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465924075375/0001104659-24-075375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465924075375/tm2418313d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:55:44.215824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}